CLM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clearside Biomedical Inc

Watchlist Manager

Watchlist

Price: 4.38 EUR Market Closed

Market Cap: €273.4m

C	Clearside Biomedical Inc XMUN:CLM	US
	Aligos Therapeutics Inc NASDAQ:ALGS	US
C	Chow Tai Fook Jewellery Group Ltd XMUN:1CT	HK

Profitability Summary

Clearside Biomedical Inc's profitability score is 43/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

58% > 90%

Negative Operating Margin

-525%

Negative 3Y Average Operating Margin

-822%

Operating Margin is Increasing

-1.831% > -525%

Negative Net Margin

-665%

Negative 3Y Average Net Margin

-1.013%

Net Margin is Increasing

-2.215% > -665%

Negative Free Cash Flow Margin

-534%

Negative 3Y Average Free Cash Flow Margin

-720%

Free Cash Flow Margin is Increasing

-1.594% > -534%

Exceptional ROE

72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1.279%

ROIC is Increasing

-4.237% > -573%

View All

Hide

Collapse

43 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.